These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 1956910

  • 1. Human cytochromes P450: evolution, catalytic activities and interindividual variations in expression.
    Gonzalez FJ, Gelboin HV.
    Prog Clin Biol Res; 1991; 372():11-20. PubMed ID: 1956910
    [No Abstract] [Full Text] [Related]

  • 2. Polymorphic oxidation of debrisoquine and sparteine.
    Eichelbaum M.
    Prog Clin Biol Res; 1986; 214():157-67. PubMed ID: 3523506
    [No Abstract] [Full Text] [Related]

  • 3. Molecular genetics of the debrisoquin-sparteine polymorphism.
    Gonzalez FJ, Meyer UA.
    Clin Pharmacol Ther; 1991 Sep; 50(3):233-8. PubMed ID: 1680592
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
    Patten CJ, Koch P.
    Arch Biochem Biophys; 1995 Mar 10; 317(2):504-13. PubMed ID: 7893169
    [Abstract] [Full Text] [Related]

  • 9. [Clinical aspects of the polymorphism of oxidation phenotype].
    Mrozikiewicz PM.
    Pol Tyg Lek; 1995 Mar 10; 47(27-28):608-10. PubMed ID: 1488339
    [No Abstract] [Full Text] [Related]

  • 10. Gas chromatography/mass spectrometry assays for the determination of debrisoquine and sparteine metabolites in microsomal fractions of rat liver.
    Ho JW, Moody DE.
    Anal Biochem; 1992 Jun 10; 203(2):348-51. PubMed ID: 1416032
    [Abstract] [Full Text] [Related]

  • 11. Role of genetic polymorphism in psychopharmacology--an update.
    Brøsen K, Sindrup SH, Skjelbo E, Nielsen KK, Gram LF.
    Psychopharmacol Ser; 1993 Jun 10; 10():199-211. PubMed ID: 8361977
    [No Abstract] [Full Text] [Related]

  • 12. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
    Chun YJ, Shimada T, Guengerich FP.
    Arch Biochem Biophys; 1996 Jun 01; 330(1):48-58. PubMed ID: 8651703
    [Abstract] [Full Text] [Related]

  • 13. [The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs].
    Brøsen K.
    Ugeskr Laeger; 1991 Feb 04; 153(6):417-22. PubMed ID: 2000644
    [Abstract] [Full Text] [Related]

  • 14. Some aspects of interindividual variations in the metabolism of xenobiotics.
    Tamási V, Vereczkey L, Falus A, Monostory K.
    Inflamm Res; 2003 Aug 04; 52(8):322-33. PubMed ID: 14504670
    [Abstract] [Full Text] [Related]

  • 15. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.
    Gonzalez FJ, Gelboin HV.
    Drug Metab Rev; 1994 Aug 04; 26(1-2):165-83. PubMed ID: 8082563
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M, Pelkonen O.
    IARC Sci Publ; 1999 Aug 04; (148):13-22. PubMed ID: 10493245
    [Abstract] [Full Text] [Related]

  • 19. A conserved proline-rich sequence between the N-terminal signal-anchor and catalytic domains is required for assembly of functional cytochrome P450 2C2.
    Chen CD, Doray B, Kemper B.
    Arch Biochem Biophys; 1998 Feb 15; 350(2):233-8. PubMed ID: 9473296
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
    Raza H, King RS, Squires RB, Guengerich FP, Miller DW, Freeman JP, Lang NP, Kadlubar FF.
    Drug Metab Dispos; 1996 Apr 15; 24(4):395-400. PubMed ID: 8801053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.